DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
Open Access
- 28 August 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (9) , 2553
Abstract
(1) Background: Epithelial–mesenchymal plasticity (EMP) is a dynamic process whereby epithelial carcinoma cells reversibly acquire morphological and invasive characteristics typical of mesenchymal cells. Identifying the methylation differences between epithelial and mesenchymal states may assist in the identification of optimal DNA methylation biomarkers for the blood-based monitoring of cancer. (2) Methods: Methylation-sensitive high-resolution melting (MS-HRM) was used to examine the promoter methylation status of a panel of established and novel markers in a range of breast cancer cell lines spanning the epithelial–mesenchymal spectrum. Pyrosequencing was used to validate the MS-HRM results. (3) Results: VIM, DKK3, and CRABP1 were methylated in the majority of epithelial breast cancer cell lines, while methylation of GRHL2, MIR200C, and CDH1 was restricted to mesenchymal cell lines. Some markers that have been used to assess minimal residual disease such as AKR1B1 and APC methylation proved to be specific for epithelial breast cell lines. However, RASSF1A, RARβ, TWIST1, and SFRP2 methylation was seen in both epithelial and mesenchymal cell lines, supporting their suitability for a multimarker panel. (4) Conclusions: Profiling DNA methylation shows a distinction between epithelial and mesenchymal phenotypes. Understanding how DNA methylation varies between epithelial and mesenchymal phenotypes may lead to more rational selection of methylation-based biomarkers for circulating tumour DNA analysis.Keywords
All Related Versions
Funding Information
- National Breast Cancer Foundation (CG10-04, CG12-07, PS-15-048,)
This publication has 62 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Suppression of the Epithelial–Mesenchymal Transition by Grainyhead-like-2Cancer Research, 2012
- DNA methylation profiling reveals a predominant immune component in breast cancersEMBO Molecular Medicine, 2011
- Subtype and pathway specific responses to anticancer compounds in breast cancerProceedings of the National Academy of Sciences, 2011
- Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of RecurrenceCancer Research, 2011
- Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesisOncogene, 2011
- Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lensChemico-Biological Interactions, 2011
- A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykBritish Journal of Cancer, 2010
- Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt SignalingCold Spring Harbor Perspectives in Biology, 2009
- Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylationNucleic Acids Research, 2007